Ergebnis der Suchanfrage nach Therapie
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- Ein Dokumentmehr
- 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr canSERV relaunches Open Call for Service Provision
Ein DokumentmehrPress release: STADA continues strong growth journey in the first half of 2024
Ein DokumentmehrcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 DokumentemehrPress release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
Ein DokumentmehrPress release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
Ein Dokumentmehr- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
Ein Dokumentmehr - 2
PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador
2 Dokumentemehr Press release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
Ein DokumentmehrPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Ein Dokumentmehr- 5
Reflecting on a successful Pharma Forum 2023
Ein Dokumentmehr - 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr - 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
Ein Dokumentmehr Press release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe
Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...
Ein Dokumentmehr- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
Ein Dokumentmehr - 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
Ein Dokumentmehr - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
Ein Dokumentmehr - 2
Lindis Biotech develops immunotherapy against bladder cancer
Ein Dokumentmehr - 2
A higher omega-3 level apparently protects from dying from COVID-19
Ein Dokumentmehr - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
Ein Dokumentmehr KOPIE VON: Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
Enclosed we send you the news of the day about the IZB. We would be pleased if you would consider the message in your news coverage. If you have any question ...
Ein DokumentmehrKOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB
Ein DokumentmehrInspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB
Ein DokumentmehrThe development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB
Ein DokumentmehrHigh investor density at the Pitch Day hosted by IZB
Ein Dokumentmehr